Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global aortic stent graft market size was valued at USD 3.1 billion in 2023, driven by technological advancements in stent graft material and design across the globe. The market is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to rise from USD 3.3 billion in 2024 to USD 5.2 billion by 2032.
An aortic stent graft is a tube consisting of fabric supported by a stent (a metal mesh). This stent graft is commonly used to treat a weak spot in an artery known as an aneurysm by sealing the artery both above and below the aneurysm. Aortic stent grafts allow blood to pass through the aorta and prevent the rupture of the aneurysm. It is primarily used to treat abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs).
One of the key factors driving the aortic stent graft market growth is the rising prevalence of aortic aneurysms, which is characterized by the ballooning and weakening of the largest blood vessel in the body. This increase in the patient population directly impacts the demand for aortic stent grafts in the market. In addition, the COVID-19 pandemic has also influenced the market landscape. In May 2023, a study revealed that abdominal aortic aneurysm patients with a history of COVID-19 infection are 9.7 times more susceptible to experiencing rapid growth of their aneurysms. As a result, the need for innovative aortic stent grafts to reinforce the aorta wall and prevent the weak area from rupturing has become critical.
Several key market players are actively engaged in research and development activities aimed at technological innovation in stent grafts. Moreover, they are significantly investing in off-the-shelf or custom-made stent graft systems to meet the growing demand for personalized treatment, which is expected to boost the aortic stent graft market share in the coming years. In January 2024 , Endospan Ltd., an Israel based company specializing in off-the-shelf endovascular repair of aortic arch disease shared 30-day results from TRIOMPHE investigational device exemption (IDE) study of its product Nexus aortic arch stent graft system at the annual meeting of the Society of Thoracic Surgeons.
The clinical study in the first 22 patients, evaluating the effectiveness and safety of Endospan’s endovascular Nexus device in treating thoracic aortic lesions, revealed positive results with low mortality rate, no paraplegia, disabling strokes, or renal failure. Additionally, the data reported short intensive care units and hospital lengths of stay of the patients, indicating the efficacy of Nexus as a minimally invasive solution for aortic repair. While the product is available for investigational use in the United States, it is already approved in Europe. The rising accessibility and adoption of such innovative devices in the healthcare sector are likely to augment the market value in the forecast period.
Key Trends | Impact |
Technological Advancements | One of the significant market trends is the continuous innovation in stent graft materials and design has significantly improved the durability and flexibility of aortic stent grafts. These advancements have allowed the treatment of patients with challenging access to anatomy and reduced procedural complications. Additionally, improvements in imaging technologies and computational modeling result in better patient outcomes and reduced rates of endoleaks and graft migrations. |
Growing Geriatric Population | The increase in the aging population, who are at a higher risk for aortic aneurysms is expected to drive the aortic stent graft market demand. This trend leads to a higher prevalence of cardiovascular diseases, including abdominal and thoracic aortic aneurysms. The growing elderly population size is a critical factor in the rising demand for stent grafts, fuelling innovation and supply to meet healthcare needs. |
Rising Demand for Minimally Invasive Procedures | The rising patient’s inclination towards minimally invasive surgeries is due to their benefits, such as reduced recovery times and fewer complications. This trend significantly impacts the aortic stent graft market by increasing the demand for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) procedures over traditional open surgeries. This propels the demand for stent grafts as they are essential components of these minimally invasive treatments. |
Increased Focus on Customization | The market is witnessing an increased focus on the customization of aortic stent grafts to align with the patient’s anatomy and disease specifics. Custom-made or off-the-shelf modular stent graft systems provide a more precise fit, reducing the risk of endoleaks significantly. This growing interest in personalized medicine in the vascular domain enhances the procedural success rate and patient satisfaction, accelerating market growth. |
Market Breakup by Product
By product, the market includes abdominal aortic stent grafts and thoracic aortic stent grafts. Abdominal aortic stent grafts are primarily used for abdominal aortic aneurysms (AAAs) whereas thoracic aortic stent grafts are used in the treatment of aneurysms and tears in the thoracic aorta, which is located in the chest.
Market Breakup by End User
In terms of end-users, the aortic stent graft market share includes hospitals, ambulatory surgical centers, and other healthcare facilities where patients undergo interventional procedures for aortic conditions.
Market Breakup by Region
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds a significant share of the market which can be attributed to the evolving regulatory policies, the growing inclination of patients towards minimally invasive procedures, and the rising demand for customized aortic stent grafts.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 3.1 billion in 2023 driven by technological advancements in stent graft material and design across the globe.
The market is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, likely to reach a market value of USD 5.2 billion by 2032.
The market demand is driven by rise in the aging population, who are at a higher risk for aortic aneurysms along with increasing healthcare expenditures.
One of the significant trends in the market is the development of minimally invasive aortic stent grafts by the leading market players. In January 2024 , Endospan Ltd specializing in off-the-shelf endovascular repair of aortic arch disease shared 30-day results from TRIOMPHE investigational device exemption (IDE) study of its product Nexus aortic arch stent graft system at the annual meeting of the Society of Thoracic Surgeons.
On the basis of product, the market includes into abdominal aortic stent grafts and thoracic aortic stent grafts.
Major end users of the market include hospitals, and ambulatory surgical centers, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Cook Group Incorporated, W. L. Gore & Associates, Inc., Medtronic, Terumo Corporation, Cordis, Artivion, Inc, Endologix LLC, Lombard Medical, SB-KAWASUMI LABORATORIES, INC., Endospan, LifeTech Scientific Corporation, Shanghai MicroPort Medical (Group) Co. Ltd., Becton, Dickinson and Company, and Cardinal Health.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share